Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,127.3
12.3 (0.39%)

 

  • STI Straits Times Index
    3,127.3
    12.3 (0.39%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,597.4
    -1.8 (-0.11%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,176.0
    441.8 (1.72%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,838.9
    15.1 (0.53%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    20,509.4
    90.5 (0.44%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,313.8
    27.1 (0.43%)
    Index delayed 10 minutes
  • KOR KOSPI
    1,935.2
    8.0 (0.42%)
    Index delayed 20 minutes
  • XAO XAO
    6,537.7
    51.8 (0.80%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 277.7M
  • Value: 241.3M
  • Rise: 114
  • Fall: 66
  • Unch: 656

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
YZJ Shipbldg SGD1.060+0.070
LionGold0.001-
Rex Intl0.074+0.006
Genting Sing0.885+0.010
Thomson Medical0.060+0.002
Seroja Inv^0.083+0.005
Reenova Investment^0.003-
Koh Eco0.049+0.003
Synagie0.164+0.002
HPH Trust USD0.182-

World Indices

World Indices
Name Last Change
Nasdaq 7,896.0 +129.4
HSI 26,180.1 +445.9
HSCEI 10,090.7 +126.4
Jakarta 6,308.5 +21.9
Nikkei 225 20,519.8 +101.0
SSE Comp 2,837.2 +13.4
Shanghai A 2,972.2 +14.0
Shanghai B 261.8 +1.2
PSE Comp 0.0
KOSPI 1,935.6 +8.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Biolidics BIOLIDICS LIMITED
Quotes 10 Minutes Delayed. Updated at 19 Aug 2019 10:10
Last (SGD): 0.220 Change: - High: - Remarks: -
Change (%): - Low: -
Open - Yesterday's Close 0.220
Buy Price 0.210 Sell Price 0.230
Buy Volume ('000) 3.5 Sell Volume ('000) 35.5
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.02578 Trailing EPS (SGD) e -0.02578 NAV (SGD) b 0.0445
PE a - Trailing PE f - Price / NAV b 4.9438
Dividend (SGD) d - Cash In Hand (SGD) g 0.0374 Issued & Paid-up Shares c 242,500,000
Dividend Yield (%) d - Price / Cash In Hand g 5.882 Treasury Shares h -
Beta - 75 Daysi 1.183 R-Squared - 75 Days(%)i 10.20 Market Cap (M) 53.350
Beta - 500 Daysi 1.337 R-Squared - 500 Days (%)i 6.27 Enterprise Value (M) 44.380
Piotroski F Score - Exchange Code 8YY Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 6-Month VWAP 0.282 Free Float (%) 99.6
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Prof, Scientific & Technical Activities - Medical Specialties
Category Classification Medical & Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Biolidics SGX 53.350 - - 4.9438 -
Industry Medical & Biotechnology SGX 1,026.771 23.435 26.816 1.4299 1.835
Medical Specialties SGX 664.771 31.419 31.810 3.9055 1.833
Local Peer Top Glove SGX 3,840.883 26.600 26.696 4.6512 1.892
Local Peer UG Healthcare SGX 34.794 8.025 10.560 0.8072 1.293
Local Peer Yunnan Energy SGX 26.442 - - 0.5069 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Local Peer Medtecs Intl SGX 16.482 13.216 13.218 0.1938 -
Global Peer ABBOTT LABORATORIES NYSE 149,840.172 63.681 52.100 4.7289 1.359
Global Peer MEDTRONIC PLC NYSE 137,817.602 29.760 29.760 2.7513 1.946
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 110,591.447 37.642 31.232 3.8495 0.265
Global Peer DANAHER CORP NYSE 100,682.599 37.981 41.155 3.2901 0.446
Global Peer STRYKER CORP NYSE 80,963.785 22.787 22.807 6.7792 0.892
Global Peer BECTON DICKINSON & CO NYSE 67,037.677 421.620 85.507 3.1188 1.200
Global Peer BOSTON SCIENTIFIC CORP NYSE 58,713.685 35.137 42.059 6.2296 -
Global Peer INTUITIVE SURGICAL INC NASDAQ 57,102.099 50.627 47.200 7.8596 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 45,615.920 63.163 62.927 13.0320 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,403.055 27.342 28.068 5.6839 0.843
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), RESMED INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), WATERS CORP (NYSE), HOLOGIC INC (NASDAQ), STERIS PLC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), NOVOCURE LTD (NASDAQ), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), COCHLEAR LTD (ASX), MASIMO CORPORATION (NASDAQ), QIAGEN NV (NYSE), HAEMONETICS CORP (NYSE), HILL-ROM HOLDINGS INC (NYSE), BRUKER CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), HARTA (Bursa), WEIGAO GROUP (HKEx), LIVANOVA PLC (NASDAQ), CANTEL MEDICAL CORP (NYSE), NEOGEN CORP (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), ICU MEDICAL INC (NASDAQ), NUVASIVE INC (NASDAQ), TOPGLOV (Bursa), WRIGHT MEDICAL GROUP NV (NASDAQ), CONMED CORP (NASDAQ), QUIDEL CORP (NASDAQ), NEVRO CORP (NYSE), EBOS GROUP (ASX), GLAUKOS CORPORATION (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), STAAR SURGICAL CO (NASDAQ), BIOTELEMETRY INC (NASDAQ), ATRION CORP (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), MICROPORT (HKEx), SHOCKWAVE MEDICAL INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ATRICURE INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), CAREDX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CRYOLIFE INC (NYSE), NANOSONICS LIMITED (ASX), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), INOGEN INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CORINDUS VASCULAR ROBOTICS INC (NYSE American), CIRC (HKEx), CERUS CORP (NASDAQ), LIFETECH SCI (HKEx), QUOTIENT LTD (NASDAQ), VERICEL CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), AK MEDICAL (HKEx), AXOGEN INC (NASDAQ), SURMODICS INC (NASDAQ), HESKA CORP (NASDAQ), ANTARES PHARMA INC (NASDAQ), SI BONE INC (NASDAQ), SUPERMX (Bursa), CORMEDIX INC (NYSE American), ORTHOPEDIATRICS CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), VIEWRAY INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), YESTAR HEALTH (HKEx), ESTABLISHMENT LABS HLDGS INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), BIOLIFE SOLUTIONS INC (NASDAQ), AVEDRO INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ZYNEX INC (NASDAQ), SIENTRA INC (NASDAQ), GOLDEN MEDITECH (HKEx), VAPOTHERM INC (NYSE), ENLIVEX THERAPEUTICS LTD (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), ACCURAY INCORPORATED (NASDAQ), IRADIMED CORP (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), CRH MEDICAL CORP (NYSE American), RTI SURGICAL HOLDINGS INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), PW MEDTECH (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MISONIX INC (NASDAQ), NEURONETICS INC (NASDAQ), SOLITON INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), FONAR CORP (NASDAQ), INTRICOM CORP (NASDAQ), INVACARE CORP (NYSE), CYTOSORBENTS CORP (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), MODERN DENTAL (HKEx), CONFORMIS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ENDOLOGIX INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), YUNNAN ENERGY (HKEx), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), SOMNOMED LIMITED (ASX), STRATA SKIN SCIENCES INC (NASDAQ), COMPUMEDICS (ASX), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), NEUROTROPE INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), ONCOCYTE CORP (NYSE American), CYCLOPHARM LIMITED (ASX), KELFRED (HKEx), SDI LTD (ASX), ELLEX MEDICAL LASERS LTD (ASX), ALPHA PRO TECH (NYSE American), NEPHROS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), VINCENT MED (HKEx), ZOSANO PHARMA CORP (NASDAQ), MRI INTERVENTIONS INC (NYSE American), ELECTROCORE INC (NASDAQ), IMPEDIMED LIMITED (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), ELECTROMED INC (NYSE American), IMMUCELL CORP (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), OVENTUS MEDICAL LTD (ASX), CELSION CORPORATION (NASDAQ), IRIDEX CORP (NASDAQ), RESPIRI LTD (ASX), DAXOR CORP (NYSE American), PAVMED INC (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), MICRO-X LTD (ASX), RESONANCE HEALTH LTD (ASX), BIOMERICA INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), NUVECTRA CORPORATION (NASDAQ), RESTORATION ROBOTICS INC (NASDAQ), BIOLASE INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), REWALK ROBOTICS LTD (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), NEOVASC INC (NASDAQ), LIFE HEALTHCARE (HKEx), ATOSSA GENETICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), ADVENTA (Bursa), OBJ LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), INSPIREMD INC (NYSE American), CHECK-CAP LTD (NASDAQ), LBT INNOVATIONS LTD (ASX), LIANLUO SMART LIMITED (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), CYANOTECH CORP (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), OPTISCAN IMAGING (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), AVINGER INC (NASDAQ), DIMERIX LTD (ASX), ANALYTICA (ASX), USCOM LTD (ASX), LKL (Bursa), DIGIRAD CORP (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CESCA THERAPEUTICS INC (NASDAQ), HUAKANG BIOMED (HKEx), MICRON SOLUTIONS INC (NYSE American), CHF SOLUTIONS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), AETHLON MEDICAL (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), STHAI (SET), CH DEMETER FIN (HKEx), SINTX TECHNOLOGIES INC (NASDAQ), NEUROMETRIX INC (NASDAQ), METALICITY LIMITED (ASX), ADHERIUM LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MY MEDICARE (HKEx), COMBEST HOLD (HKEx), ADMEDUS LTD (ASX), MEDIGARD LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.005
-2.22 %
10 Days --0.035
-13.73 %
20 Days --0.060
-21.43 %
Medium Term Return 3 Months --0.070
-24.14 %
6 Months --0.095
-30.16 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.180 - 0.330 Change From 1 Year Low +0.040 % Change From 1 Year Low (%) +22.22
Change From 1 Year High -0.110 % Change From 1 Year High (%) -33.33
2 Years Range 0.180 - 0.330 Change From 2 Years Low +0.040 % Change From 2 Years Low (%) +22.22
Change From 2 Years High -0.110 % Change From 2 Years High (%) -33.33
5 Years Range 0.180 - 0.330 Change From 5 Years Low +0.040 % Change From 5 Years Low (%) +22.22
Change From 5 Years High -0.110 % Change From 5 Years High (%) -33.33
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide.The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

IPO Performance

Listing Date 19 Dec 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 27.50 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.235 First Week Close (SGD) 0.230
Current vs IPO Price (%) -21.43 First Day Gain (%) -16.07 First Week Gain (%) -17.86

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(3.41 MB)
IPO Prospectus
IPO Prospectus 2018 Dec 2018 Part 1(2.88 MB)
Part 2(0.53 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
16 Aug 2019 0.220 0.220 0.200 0.220 69,900 0.2151
15 Aug 2019 0.225 0.230 0.215 0.230 15,200 0.2251
14 Aug 2019 0.210 0.235 0.210 0.235 31,100 0.2218
13 Aug 2019 0.215 0.225 0.210 0.225 101,300 0.2129
08 Aug 2019 0.225 0.225 0.225 0.225 - -
07 Aug 2019 0.230 0.245 0.225 0.225 128,700 0.2290
06 Aug 2019 0.240 0.240 0.220 0.240 63,600 0.2378
05 Aug 2019 0.245 0.250 0.220 0.250 71,300 0.2438
02 Aug 2019 0.255 0.265 0.250 0.255 201,100 0.2523
01 Aug 2019 0.260 0.260 0.255 0.260 27,100 0.2557
31 Jul 2019 0.260 0.270 0.260 0.270 6,500 0.2603
30 Jul 2019 0.265 0.265 0.260 0.260 320,000 0.2627
29 Jul 2019 0.265 0.270 0.265 0.270 110,200 0.2650
26 Jul 2019 0.270 0.270 0.270 0.270 - -
25 Jul 2019 0.270 0.270 0.270 0.270 - -
24 Jul 2019 0.270 0.270 0.270 0.270 - -
23 Jul 2019 0.260 0.270 0.250 0.270 35,300 0.2530
22 Jul 2019 0.280 0.280 0.280 0.280 - -
19 Jul 2019 0.270 0.280 0.270 0.280 11,700 0.2702
18 Jul 2019 0.280 0.280 0.275 0.280 38,000 0.2776
17 Jul 2019 0.280 0.280 0.280 0.280 - -
16 Jul 2019 0.280 0.280 0.280 0.280 - -
Summary
Current 2 Weeks
(01 Aug 2019 to 16 Aug 2019)
0.260 0.265 0.200 0.220 709,300 -
Previous 2 Weeks
(18 Jul 2019 to 31 Jul 2019)
0.280 0.280 0.200 0.270 521,700 -
4 Weeks from
(20 Jun 2019 to 17 Jul 2019)
0.290 0.290 0.200 0.280 2,042,900 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.